1-6 of 6
Andras Matolcsy, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comprehensive Profiling of Disease-Relevant Copy Number Aberrations Improves Risk Assessment and Unveils the Clonal Origin of Relapse in Pediatric Acute Lymphoblastic Leukemia

Donát Alpár, PhD, Richárd Kiss, MD, Ambrus Gángó, MD, Anne Benard-Slagter, PhD, Bálint Egyed, MD, Irén Haltrich, PhD, Lajos Hegyi, MSc, Karel de Groot, PhD, Péter Attila Király, MD PhD, Szilvia Krizsán, MD, Béla Kajtár, MD PhD, Henriett Pikó, PhD, László Pajor, MD PhD DSc, Ágnes Vojcek, MD, András Matolcsy, MD PhD DSc, Gábor Kovács, MD PhD DSc, Károly Szuhai, MD PhD, Suvi Savola, PhD, Csaba Bödör, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1474.
https://doi.org/10.1182/blood-2019-128699
Published: 2019
Journal Articles

Spatial Convergent Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression in Chronic Lymphocytic Leukemia

Richárd Kiss, Donát Alpár, PhD, Ambrus Gángó, MD, Noémi Nagy, Dora Aczel, Andras Matolcsy, MD PhD, Judit Csomor, Zoltán Mátrai, MD PhD, Csaba Bödör, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5539.
https://doi.org/10.1182/blood-2018-99-115937
Published: 2018
Journal Articles

Cell of Origin and Genomic Profile of Primary Central Nervous System Lymphoma Determined Using the Nanostring Lst Assay and Ultra Deep Targeted Next Generation Sequencing

Csaba Bödör, PhD, Donát Alpár, PhD, Dóra Marosvári, MD, Hajnalka Rajnai, MD PhD, Bianka Dudela, Béla Kajtár, MD PhD, Beáta Deák, MD PhD, Andras Matolcsy, MD PhD, Sebastian Brandner, MD PhD, James Storhoff, PhD, Nadeem Ghali, PharmD, Lilla Reiniger, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4009.
https://doi.org/10.1182/blood.V130.Suppl_1.4009.4009
Published: 2017
Journal Articles

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib

Donát Alpár, PhD, Dóra Marosvári, MD, Richárd Kiss, Viktória Fésüs, Ambrus Gángó, MD, Noémi Nagy, Péter Farkas, MD, Szabolcs Tasnády, PhD, Marienn Réty, MD, Andras Matolcsy, MD PhD, Zoltán Mátrai, MD PhD, Csaba Bödör, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1457.
https://doi.org/10.1182/blood.V130.Suppl_1.1457.1457
Published: 2017
Journal Articles

High Incidence of EZH2 Mutations with Variable Mutation Load in Follicular Lymphoma and Its Consequences for EZH2 Targeted Therapy

Csaba Böodöor, PhD, Grossmann Vera, Alexander Kohlmann, PhD, King Tan, MBBS, Jessica Okosun, MD, Nikolay Popov, PhD, Shamzah Araf, MD, Jacek Marzec, Ciaran O‘Riain, MD, PhD, Abigail Lee, MD, PhD, Andrew James Clear, BSc, Silvia Montoto, MD, Janet Matthews, Sameena Iqbal, Hajnalka Rajnai, MD, Andreas Rosenwald, MD, German Ott, MD, Elias Campo, MD, PhD, Erlend B. Smeland, MD, Wing C. Chan, MD, Rita M. Braziel, MD, Louis M. Staudt, MD, PhD, George Wright, PhD, Lisa M. Rimsza, MD, T. Andrew Lister, MD, Olivier Elemento, PhD, John G Gribben, Andras Matolcsy, MD, PhD, Torsten Haferlach, MD, Randy D. Gascoyne, MD, Jude Fitzgibbon, PhD
Journal: Blood
Blood (2012) 120 (21): 545.
https://doi.org/10.1182/blood.V120.21.545.545
Published: 2012
Journal Articles

Immunochemotherapy As Induction (R-CHOP and R-HyperC-VAD/R-MA) in Mantle Cell Lymphoma, a Hungarian Multicenter Open Label Phase II Study (Rituximab [MabThera®] in Mantle Cell Lymphoma, REMENY)

Miklos Udvardy, MD, PhD, Andras Rosta, MD, PhD, Zoltan Gasztonyi, MD, Zita Borbenyi, MD, PhD, Gaspar Radvanyi, MD, Miklos Egyed, MD, PhD, Beata Gasztonyi, MD, PhD, Hajna Losonczy, MD, PhD, Andras Matolcsy, MD, PhD, Agnes H. Andrasfalvy, MD, Tamas J. Schneider, MD
Journal: Blood
Blood (2012) 120 (21): 4889.
https://doi.org/10.1182/blood.V120.21.4889.4889
Published: 2012